Advisor Group Holdings, Inc. Opiant Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$9.38 - $20.29 $2,814 - $6,087	-300 Reduced 5.17%	5,500 $111,000
Q3 2022 Nov 14, 2022	BUY	$9.52 - $13.48 $2,856 - $4,044	300 Added 5.45%	5,800 $62,000
Q2 2022 Aug 10, 2022	BUY	$10.12 - $23.32 $758 - $1,749	75 Added 1.38%	5,500 $66,000
Q1 2022 May 04, 2022	SELL	$19.54 - $33.59 $17,586 - $30,231	-900 Reduced 14.23%	5,425 $116,000
Q3 2021 Nov 05, 2021	BUY	$13.28 - $25.79 $42,496 - $82,528	3,200 Added 102.4%	6,325 $163,000
Q1 2021 May 13, 2021	SELL	$8.2 - $14.49 $2,050 - $3,622	-250 Reduced 7.41%	3,125 $32,000
Q4 2020 Feb 10, 2021	SELL	$6.87 - $8.88 $1,374 - $1,776	-200 Reduced 5.59%	3,375 $27,000
Q2 2020 Aug 14, 2020	SELL	$8.64 - $11.87 $10,368 - $14,243	-1,200 Reduced 25.13%	3,575 $32,000
Q1 2020 May 18, 2020	BUY	$9.11 - $14.42 $43,500 - $68,855	4,775 New	4,775 $45,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.